You are here

Clinical Trials: Heart Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, July 20, 2020 - 12:00
Condition:   Non-ischemic Dilated Cardiomyopathy
Interventions:   Biological: allogeneic human mesenchymal stem cells (hMSCs);   Other: Placebo
Sponsors:   Joshua M Hare;   United States Department of Defense;   The University of Texas Health Science Center, Houston
Not yet recruiting
Posted: Friday, May 22, 2020 - 12:00
Condition:   Heart Failure
Intervention:   Biological: EHM implantation
Sponsors:   University Medical Center Goettingen;   Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK);   University Medical Center Freiburg
Not yet recruiting
Posted: Friday, April 10, 2020 - 12:00
Condition:   Respiratory Tract Diseases
Intervention:   Drug: Stem Cell Product
Sponsor:   Rigshospitalet, Denmark
Not yet recruiting
Posted: Thursday, April 9, 2020 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Mesenchymal Stem Cells
Sponsor:   PT. Prodia Stem Cell Indonesia
Posted: Monday, April 6, 2020 - 12:00
Condition:   Heart Failure
Intervention:   Other: Exercise Training Program
Sponsors:   Centro Hospitalar do Porto;   Universidade do Porto;   Aveiro University
Posted: Tuesday, March 31, 2020 - 12:00
Condition:   Heart Attack
Intervention:   Drug: PEP in Acute Myocardial Infarction
Sponsor:   Paul G. Stalboerger
Not yet recruiting
Posted: Wednesday, February 19, 2020 - 12:00
Condition:   Coronavirus
Intervention:   Biological: MSCs-derived exosomes
Sponsors:   Ruijin Hospital;   Shanghai Public Health Clinical Center;   Wuhan Jinyintan Hospital, Wuhan, China;   Cellular Biomedicine Group Ltd.
Not yet recruiting
Posted: Tuesday, November 5, 2019 - 12:00
Condition:   Patients
Interventions:   Other: Incremental cycling test (ICT);   Other: Constant load cycling test (CET);   Other: Incremental respiratory muscle test (IncRMET);   Other: Incremental quadriceps muscle test (IncQMT);   Other: Respiratory muscle training like interventions
Sponsor:   Swiss Federal Institute of Technology
Posted: Wednesday, August 14, 2019 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Posted: Friday, August 9, 2019 - 12:00
Condition:   Coronary Artery Disease
Intervention:   Biological: MCRcI® stem cells
Sponsors:   Honya Medical Inc;   Chang Gung Memorial Hospital